v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   4,578,841      
Beginning balance at Dec. 31, 2023 $ 290,610 $ 0 $ 787,851 $ (6,497) $ (490,744)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for vesting of stock awards (in shares)   29,301      
Shares repurchased for withholding tax on stock awards (in shares)   (104,973)      
Shares repurchased for withholding tax on stock awards (97)   (97)    
Stock-based compensation expense 853   853    
Net loss (12,608)       (12,608)
Foreign currency translation gain (loss) (729)     (729)  
Ending balance (in shares) at Mar. 31, 2024   4,503,169      
Ending balance at Mar. 31, 2024 $ 278,029 $ 0 788,607 (7,226) (503,352)
Beginning balance (in shares) at Dec. 31, 2024 4,614,279 4,614,279      
Beginning balance at Dec. 31, 2024 $ 223,722 $ 0 790,094 (8,911) (557,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for vesting of stock awards (in shares)   2,267      
Shares repurchased for withholding tax on stock awards (in shares)   (821)      
Shares repurchased for withholding tax on stock awards (3)   (3)    
Stock-based compensation expense 474   474    
Net loss (14,385)       (14,385)
Foreign currency translation gain (loss) $ 137     137  
Ending balance (in shares) at Mar. 31, 2025 4,615,725 4,615,725      
Ending balance at Mar. 31, 2025 $ 209,945 $ 0 $ 790,565 $ (8,774) $ (571,846)